摘要
摘要目的研究美托洛尔与胺碘酮联合在冠心病心律不齐疾病治疗中的临床运用效果.方法按随机数字表法,将８２例冠心病心律不齐患者均分成对照组与联合组,前者予以碘胺酮,后者予以碘胺酮＋美托洛尔.观察与比较两组患者的临床治疗效果.结果联合组患者治疗后的有效率(９５．１％)显著高于对照组(６５．９％),差异存在统计学意义(P＜０．０５);联合组患者治疗后的心率、血压等均优于对照组,差异有统计学意义(P＜０．０５).结论对冠心病心律不齐患者予以胺碘酮与美托洛尔联合治疗,疗效甚佳,值得在临床上推行.关键词冠心病;心律不齐;美托洛尔;胺碘酮CoronaryheartdiseasearrhythmiathroughtheanalysisoftheeffectofmetoprololcombinedwithamiodaroneAbstractObjectiveStudyofmetoprololandamiodaronecombinedwithclinicalapplicationeffectintreatmentofcoronaryheartdiseasearrhythmiain．MethodAccordingtotherandomnumbertablemethod,the８２casesofcoronaryheartdiseasepatientswitharrhythmiaweredividedintocontrolgroupandcombinationgroup,theformertobeamineiodineketone,thelattertobeiodineamineketone＋metoprolol．Observationandcomparisonoftwogroupsofpatientswithclinicaltherapeuticeffect．ResultsTheeffectiverate(９５．１％)ofthecombinedgroupwassignificantlyhigherthanthatinthecontrolgroup(６５．９％),thedifferencewasstatisticallysignificant(P＜０．０５);Theheartrateandbloodpressureofthecombinedgroupwerebetterthanthoseofthecontrolgroup,thedifferencewasstatistiＧcallysignificant(P＜０．０５)．ConclusionThecoronaryheartdiseasepatientswitharrhythmiatoeffectofamiodaronecombinedwithmetoprololinthetreatment,verＧygoodK,ewyorwtohrdpsursuinginclinic．Coronaryheartdisease;arrhythmia;MeiTOROM中图分类号R５４１．７文献标识码B文章编号１００８－６３１５(２０１５)１２－０９１２－０１
出版日期
2015年12月22日（中国期刊网平台首次上网日期，不代表论文的发表时间）
